Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy
Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), David A. Williams(Boston Children's Hospital), Geoffrey Parsons(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Vinod K. Prasad(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Melissa Bonner(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Marianna Foos(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Himal L. Thakar(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Melissa A. Kinney(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Jörn‐Sven Kühl(Charité - Universitätsmedizin Berlin), Florian Eichler(Harvard University), Bartosz Grzywacz(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Richard A. Colvin(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Paul J. Orchard(University of Minnesota), Sarah Slauson(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Jacob R. Bledsoe(Boston Children's Hospital), Ashish O. Gupta(University of Minnesota), Ankit Lodaya(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Amy Beckman(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Andrew C. Dietz(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Gerald Downey(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Nicole Floro(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Marian H. Harris(Boston Children's Hospital), Francis J. Pierciey(Somerville Hospital)
Cited by 119
Related Papers
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592
Hyponatremia among Runners in the Boston Marathon
|New England Journal of Medicine|2005|553
Highly efficient therapeutic gene editing of human hematopoietic stem cells
|Nature Medicine|2019|518
Institutional implementation of clinical tumor profiling on an unselected cancer population
|JCI Insight|2016|447
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
|Biology of Blood and Marrow Transplantation|2015|409